We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$265M
AUM Growth
+$1.61M
Cap. Flow
-$4.39M
Cap. Flow %
-1.66%
Top 10 Hldgs %
37.8%
Holding
155
New
33
Increased
20
Reduced
44
Closed
28

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.52M
2
CVS icon
CVS Health
CVS
+$4.51M
3
LHX icon
L3Harris
LHX
+$4.09M
4
CRM icon
Salesforce
CRM
+$3.6M
5
DLTR icon
Dollar Tree
DLTR
+$3.6M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.62M
2
V icon
Visa
V
+$5.01M
3
HUM icon
Humana
HUM
+$4.83M
4
DLR icon
Digital Realty Trust
DLR
+$4.27M
5
ROK icon
Rockwell Automation
ROK
+$4.18M

Sector Composition

Rank Sector Weight
1 Technology 36%
2 Healthcare 10.46%
3 Industrials 9.79%
4 Financials 9.61%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
101
Viking Therapeutics
VKTX
$4.02B
$225K 0.09%
+4,240
New +$278K
HCSG icon
102
Healthcare Services Group
HCSG
$1.5B
$220K 0.08%
+20,781
New +$231K
FARO
103
DELISTED
Faro Technologies
FARO
$184K 0.07%
11,510
– –
EYE icon
104
National Vision
EYE
$1.8B
$171K 0.06%
+13,036
New +$213K
UPWK icon
105
Upwork
UPWK
$1.21B
$149K 0.06%
13,822
– –
DOMO icon
106
Domo
DOMO
$189M
$148K 0.06%
19,107
– –
DBRG icon
107
DigitalBridge
DBRG
$2.95B
$147K 0.06%
10,708
– –
SD icon
108
SandRidge Energy
SD
$531M
$146K 0.06%
11,290
– –
XERS icon
109
Xeris Biopharma Holdings
XERS
$1.46B
$120K 0.05%
53,211
– –
CTOS icon
110
Custom Truck One Source
CTOS
$2.42B
$108K 0.04%
24,722
– –
TTI icon
111
TETRA Technologies
TTI
$1.28B
$100K 0.04%
28,817
– –
VISN
112
Vistance Networks Inc
VISN
$2.63B
$99K 0.04%
80,441
+32,948
+69% +$39.2K
NVRI icon
113
Enviri
NVRI
$615M
$99K 0.04%
11,505
– –
PTLO icon
114
Portillo's
PTLO
$325M
$99K 0.04%
10,209
– –
CTLP
115
DELISTED
Cantaloupe
CTLP
$96K 0.04%
14,557
– –
ORGO icon
116
Organogenesis Holdings
ORGO
$239M
$95K 0.04%
34,105
– –
PGEN icon
117
Precigen
PGEN
$2.51B
$89K 0.03%
56,618
– –
VMD icon
118
Viemed Healthcare
VMD
$355M
$76K 0.03%
+11,561
New +$87.1K
EGAN icon
119
eGain
EGAN
$203M
$71K 0.03%
11,254
– –
SGMT icon
120
Sagimet Biosciences
SGMT
$591M
$58K 0.02%
17,056
+1,321
+8% +$6.06K
TLS icon
121
Telos
TLS
$302M
$57K 0.02%
14,218
– –
NDLS icon
122
Noodles & Co
NDLS
$96M
$50K 0.02%
3,971
– –
NB
123
NioCorp Developments
NB
$793M
$39K 0.01%
22,301
– –
CMRX
124
DELISTED
Chimerix, Inc.
CMRX
$32K 0.01%
36,171
– –
CMBM
125
DELISTED
Cambium Networks
CMBM
$29K 0.01%
10,563
– –
3 4
5
6 7

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Stoneridge Investment Partners held 155 positions worth $265M, up 0.61% from $263M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stoneridge Investment Partners's Q2 2024 filing shows 33 new, 20 increased, 44 reduced and 28 closed positions. Its largest new stake was CVS Health: 72,169 shares worth $4.26M. The largest sale was Pfizer, an estimated $6.62M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Stoneridge Investment Partners's largest Q2 2024 buy was CVS Health: 72,169 shares worth $4.26M.
  • Stoneridge Investment Partners added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.52M increase.
  • Stoneridge Investment Partners's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $2.39M.
  • Stoneridge Investment Partners fully exited Pfizer in Q2 2024, selling an estimated $6.62M.
  • Stoneridge Investment Partners's ten largest holdings make up 38% of its $265M portfolio in Q2 2024.
  • Stoneridge Investment Partners opened 33 new positions and closed 28 in Q2 2024.
  • Stoneridge Investment Partners's portfolio value rose 0.61% quarter-over-quarter to $265M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.